Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications

por Mahmood, Niaz, Mihalcioiu, Catalin, Rabbani, Shafaat A.
Publicado 2018

Abscopal Effect in a Stage IV Melanoma Patient who Progressed on Pembrolizumab

por Tsui, James M, Mihalcioiu, Catalin, Cury, Fabio L
Publicado 2018

Parathyroid Hormone‐Related Protein Inhibition Blocks Triple‐Negative Breast Cancer Expansion in Bone Through Epithelial to Mesenchymal Transition Reversal

por Li, Jiarong, Camirand, Anne, Zakikhani, Mahvash, Sellin, Karine, Guo, Yubo, Luan, XiaoRui, Mihalcioiu, Catalin, Kremer, Richard
Publicado 2022

Enhanced Anticancer Effect of a Combination of S-adenosylmethionine (SAM) and Immune Checkpoint Inhibitor (ICPi) in a Syngeneic Mouse Model of Advanced Melanoma

por Mehdi, Ali, Attias, Mikhael, Mahmood, Niaz, Arakelian, Ani, Mihalcioiu, Catalin, Piccirillo, Ciriaco A., Szyf, Moshe, Rabbani, Shafaat Ahmed
Publicado 2020

A pilot study using dynamic contrast enhanced-MRI as a response biomarker of the radioprotective effect of memantine in patients receiving whole brain radiotherapy

por Wong, Philip, Leppert, Ilana R., Roberge, David, Boudam, Karim, Brown, Paul D., Muanza, Thierry, Pike, G. Bruce, Chankowsky, Jeffrey, Mihalcioiu, Catalin
Publicado 2016

Pilot study investigating the prognostic significance of thymidine phosphorylase expression in patients with metastatic breast cancer: a single institution retrospective analysis

por Tedeschi, Anna Lisa, Eslami, Zohreh, Garoufalis, Evgenia, Saleh, Ramy R, Omeroglu, Atilla, Altinel, Gulbeyaz, Ait-Tihyaty, Maria, Jean-Claude, Bertrand, Mihalcioiu, Catalin
Publicado 2015

DNA methylation signatures of breast cancer in peripheral T-cells

por Parashar, Surabhi, Cheishvili, David, Mahmood, Niaz, Arakelian, Ani, Tanvir, Imrana, Khan, Haseeb Ahmed, Kremer, Richard, Mihalcioiu, Catalin, Szyf, Moshe, Rabbani, Shafaat A.
Publicado 2018

Impact of the 21-Gene Recurrence Score Assay on Treatment Decisions and Cost in Patients with Node-Positive Breast Cancer: A Multicenter Study in Quebec

por Hassan, Saima, Younan, Rami, Patocskai, Erica, Provencher, Louise, Poirier, Brigitte, Sideris, Luca, Dubé, Pierre, Mihalcioiu, Catalin, Chabot-Blanchet, Malorie, Guertin, Marie-Claude, Boileau, Jean-François, Robidoux, André
Publicado 2022

A phase-I study of lapatinib in combination with foretinib, a c-MET, AXL and vascular endothelial growth factor receptor inhibitor, in human epidermal growth factor receptor 2 (HER...

por Chia, Stephen K., Ellard, Susan L., Mates, Mihaela, Welch, Stephen, Mihalcioiu, Catalin, Miller, Wilson H., Gelmon, Karen, Lohrisch, Caroline, Kumar, Vikaash, Taylor, Sara, Hagerman, Linda, Goodwin, Rachel, Wang, Tao, Sakashita, Shingo, Tsao, Ming S., Eisenhauer, Elizabeth, Bradbury, Penelope
Publicado 2017

Prognostic and predictive value of circulating tumor DNA during neoadjuvant chemotherapy for triple negative breast cancer

por Cavallone, Luca, Aguilar-Mahecha, Adriana, Lafleur, Josiane, Brousse, Susie, Aldamry, Mohammed, Roseshter, Talia, Lan, Cathy, Alirezaie, Najmeh, Bareke, Eric, Majewski, Jacek, Ferrario, Cristiano, Hassan, Saima, Discepola, Federico, Seguin, Carole, Mihalcioiu, Catalin, Marcus, Elizabeth A., Robidoux, André, Roy, Josée-Anne, Pelmus, Manuela, Basik, Mark
Publicado 2020

Nivolumab improved survival vs dacarbazine in patients with untreated advanced melanoma

por Long, Georgina V, Atkinson, Victoria, Ascierto, Paolo A, Brady, Benjamin, Dutriaux, Caroline, Maio, Michele, Mortier, Laurent, Hassel, Jessica C, Rutkowski, Piotr, McNeil, Catriona, Kalinka-Warzocha, Ewa, Savage, Kerry J, Hernberg, Micaela, Lebbé, Celeste, Charles, Julie, Mihalcioiu, Catalin, Chiarion-Sileni, Vanna, Mauch, Cornelia, Schmidt, Henrik, Schadendorf, Dirk, Gogas, Helen, Horak, Christine, Sharkey, Brian, Waxman, Ian M, Robert, Caroline
Publicado 2015

Helicobacter pylori serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors

por Tonneau, Marion, Nolin-Lapalme, Alexis, Kazandjian, Suzanne, Auclin, Edouard, Panasci, Justin, Benlaifaoui, Myriam, Ponce, Mayra, Al-Saleh, Afnan, Belkaid, Wiam, Naimi, Sabrine, Mihalcioiu, Catalin, Watson, Ian, Bouin, Mickael, Miller, Wilson, Hudson, Marie, Wong, Matthew K., Pezo, Rossanna C., Turcotte, Simon, Bélanger, Karl, Jamal, Rahima, Oster, Paul, Velin, Dominique, Richard, Corentin, Messaoudene, Meriem, Elkrief, Arielle, Routy, Bertrand
Publicado 2022

Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma

por Robert, Caroline, Long, Georgina V., Brady, Benjamin, Dutriaux, Caroline, Di Giacomo, Anna Maria, Mortier, Laurent, Rutkowski, Piotr, Hassel, Jessica C., McNeil, Catriona M., Kalinka, Ewa Anna, Lebbé, Céleste, Charles, Julie, Hernberg, Micaela M., Savage, Kerry J., Chiarion-Sileni, Vanna, Mihalcioiu, Catalin, Mauch, Cornelia, Arance, Ana, Cognetti, Francesco, Ny, Lars, Schmidt, Henrik, Schadendorf, Dirk, Gogas, Helen, Zoco, Jesús, Re, Sandra, Ascierto, Paolo A., Atkinson, Victoria
Publicado 2020

Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence

por Slingluff, Craig L, Lewis, Karl D, Andtbacka, Robert, Hyngstrom, John, Milhem, Mohammed, Markovic, Svetomir N, Bowles, Tawnya, Hamid, Omid, Hernandez-Aya, Leonel, Claveau, Joel, Jang, Sekwon, Philips, Prejesh, Holtan, Shernan G, Shaheen, Montaser F, Curti, Brendan, Schmidt, William, Butler, Marcus O, Paramo, Juan, Lutzky, Jose, Padmanabhan, Arvinda, Thomas, Sajeve, Milton, Daniel, Pecora, Andrew, Sato, Takami, Hsueh, Eddy, Badarinath, Suprith, Keech, John, Kalmadi, Sujith, Kumar, Pallavi, Weber, Robert, Levine, Edward, Berger, Adam, Bar, Anna, Beck, J Thaddeus, Travers, Jeffrey B, Mihalcioiu, Catalin, Gastman, Brian, Beitsch, Peter, Rapisuwon, Suthee, Glaspy, John, McCarron, Edward C, Gupta, Vinay, Behl, Deepti, Blumenstein, Brent, Peterkin, Joanna J
Publicado 2021